Relationship between plasma homocysteine levels and congestive heart failure in patients with acute myocardial infarction-homocysteine and congestive heart failure

International Heart Journal

Volumn 52, Issue 4, 2011, Pages 224-228

  Washio, Takehiko ^a   Nomoto, Kazumiki ^a   Watanabe, Ikuyoshi ^a   Tani, Shigemasa ^a   Nagao, Ken ^a   Hirayama, Atsushi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; Congestive heart failure; Homocysteine

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HOMOCYSTEINE;

ACUTE HEART INFARCTION; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOMOCYSTEINE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 80051660096     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.52.224     Document Type: Article

References (35)

1. Mcdonald L, Bray C, Field C, Love F, Davies B. Homocystinuria, thrombosis, and the blood-platelets. Lancet 1964; 1: 745-746.
2. Brattstrom LE, Hardebo JE, Hultberg BL. Moderate homo-cysteinemia--a possible risk factor for arteriosclerotic cerebrovas-cular disease. Stroke 1984; 15: 1012-1016.
3. Bostom AG, Selhub J. Homocysteine and arteriosclerosis: sub-clinical and clinical disease associations. Circulation 1999; 99: 2361-2363.
4. McCully KS. Hyperhomocysteinemia and arteriosclerosis: historical perspectives. Clin Chem Lab Med 2005; 43: 980-986. (Review)
5. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 338: 1042-1050.
6. Aronow WS, Ahn C. Increased plasma homocysteine is an independent predictor of new coronary events in older persons. Am J Cardiol 2000; 86: 346-347.
7. Daskalopoulou SS, Pathmarajah M, Kakkos SK, et al. Association between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudication. Circ J 2008; 72: 441-448.
8. Sun Y, Chien KL, Hsu HC, Su TC, Chen MF, Lee YT. Use of serum homocysteine to predict stroke, coronary heart disease and death in ethnic Chinese. 12-year prospective cohort study. Circ J 2009; 73: 1423-1430.
9. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-1155.
10. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230-236.
11. Bostom AG, Rosenberg IH, Silbershatz H, et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med 1999; 131: 352-355.
12. Anderson JL, Muhlestein JB, Horne BD, et al. Plasma homo-cysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defned coronary artery disease. Circulation 2000; 102: 1227-1232.
13. Kim DB, Oh YS, Yoo KD, et al. Passive smoking in never-smok-ers is associated with increased plasma homocysteine levels. Int Heart J 2010; 51: 183-187.
14. Chua S, Wu CJ, Chang HW, et al. Impact of elevated plasma total homocysteine concentration on coronary atherosclerosis in Chinese patients with acute myocardial infarction undergoing primary coronary intervention. Int Heart J 2005; 46: 181-193.
15. Vasan RS, Beiser A, D'Agostino RB, et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myo-cardial infarction. JAMA 2003; 289: 1251-1257.
16. van Guldener C, Donker AJ, Jakobs C, Teerlink T, de Meer K, Stehouwer CD. No net renal extraction of homocysteine in fasting humans. Kidney Int 1998; 54: 166-169.
17. Morita H, Saito Y, Ohashi N, et al. Fluvastatin ameliorates the hy-perhomocysteinemia-induced endothelial dysfunction. Circ J 2005; 69: 475-480.
18. Lentz SR. Homocysteine and vascular dysfunction. Life Sci 1997; 61: 1205-15. (Review)
19. Chilian WM. Coronary microcirculation in health and disease. Summary of an NHLBI workshop. Circulation 1997; 95: 522-528. (Review)
20. Symons JD, Mullick AE, Ensunsa JL, Ma AA, Rutledge JC. Hyperhomocysteinemia evoked by folate depletion: effects on coronary and carotid arterial function. Arterioscler Thromb Vasc Biol 2002; 22: 772-780.
21. Lentz SR, Sobey CG, Piegors DJ, et al. Vascular dysfunction in monkeys with diet-induced hyperhomocysteinemia. J Clin Invest 1996; 98: 24-29.
22. Chambers JC, McGregor A, Jean-Marie J, Kooner JS. Acute hy-perhomocysteinaemia and endothelial dysfunction. Lancet 1998; 351: 36-37.
23. Guo H, Lee JD, Uzui H, et al. Effects of folic acid and magnesium on the production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells. Circ J 2007; 70: 141-146.
24. Tsai JC, Perrella MA, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA; 1994; 91: 6369-6373.
25. Majors A, Ehrhart LA, Pezacka EH. Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. Arterioscler Thromb Vasc Biol 1997; 17: 2074-2081.
26. Mujumdar VS, Aru GM, Tyagi SC. Induction of oxidative stress by homocysteine impairs endothelial function. J Cell Biochem 2001; 82: 491-500.
27. Miller A, Mujumdar V, Palmer L, Bower JD, Tyagi SC. Reversal of endocardial endothelial dysfunction by folic acid in homo-cysteinemic hypertensive rats. Am J Hypertens 2002; 15: 157-163.
28. Al-Obaidi MK, Stubbs PJ, Collinson P, Conroy R, Graham I, Noble MI. Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes. J Am Coll Cardiol 2000; 36: 1217-1222.
29. Loscalzo J. The oxidant stress of hyperhomocysteinemia. J Clin Invest 1996; 98: 5-7.
30. May HT, Alharethi R, Anderson JL, et al. Homocysteine levels are associated with increased risk of congestive heart failure in patients with and without coronary artery disease. Cardiology 2007; 107: 1781-84.
31. Blacher J, Demuth K, Guerin AP, et al. Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease. J Nephrol 1999; 12: 248-255.
32. Andersson SE, Edvinsson ML, Edvinsson L. Reduction of homo-cysteine in elderly with heart failure improved vascular function and blood pressure control but did not affect infammatory activity. Basic Clin Pharmacol Toxicol 2005; 97: 306-310.
33. Gibelin P, Serre S, Candito M, Houcher B, Berthier F, Baudouy M. Prognostic value of homocysteinemia in patients with congestive heart failure. Clin Chem Lab Med 2006; 44: 813-816.
34. Anderson JL, Jensen KR, Carlquist JF, Bair TL, Horne BD, Muh-lestein JB. Effect of folic acid fortification of food on homo-cysteine-related mortality. Am J Med 2004; 116: 158-164. 35.
35. Lonn E, Held C, Arnold JM, et al. Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial. Can J Cardiol 2006; 22: 47-53.